Dabigatran Falsely Elevates Point of Care International Normalized Ratio Results

被引：24

作者：

DeRemer, Christina E. ^{[1
]}

Gujral, Jaspal S. ^{[2
]}

Thornton, John W. ^{[1
]}

Sorrentino, Robert A. ^{[1
]}

机构：

[1] MCGHealth, Augusta, GA USA

[2] Georgia Hlth Sci Univ, Augusta, GA USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2011年 / 124卷 / 09期

关键词：

D O I：

10.1016/j.amjmed.2011.02.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E5 / E6

页数：2

共 2 条

[1] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[2] Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity [J].

van Ryn, Joanne ;

Stangier, Joachim ;

Haertter, Sebastian ;

Liesenfeld, Karl-Heinz ;

Wienen, Wolfgang ;

Feuring, Martin ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) :1116-1127

← 1 →